sulfaphenazole has been researched along with Primary Hyperparathyroidism in 1 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Virdis, A | 1 |
| Cetani, F | 1 |
| Giannarelli, C | 1 |
| Banti, C | 1 |
| Ghiadoni, L | 1 |
| Ambrogini, E | 1 |
| Carrara, D | 1 |
| Pinchera, A | 1 |
| Taddei, S | 1 |
| Bernini, G | 1 |
| Marcocci, C | 1 |
1 other study available for sulfaphenazole and Primary Hyperparathyroidism
| Article | Year |
|---|---|
The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Ascorbic Acid; Biological Factors; Cytochrome P-450 CYP2 | 2010 |